About ATXI

Fortress Biotech, Inc. (Fortress) is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies, also known as Fortress Companies. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies achieve their goals. Fortress and the Fortress Companies may seek licensings, acquisitions, partnerships, joint ventures and/or public and private financings to accelerate and provide additional funding to support their research and development programs.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ATXI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
IWC iShares Microcap ETF 902.6 M 9.02588E+08 1,461 1461 0.01% 0.0001 92 K 91674
WMCR Invesco Wilshire Micro-Cap ETF 21.5 M 2.15E+07 1,083 1083 0.02% 0.00019 4 K 4192

Wait, Before You Leave...